Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 176.00
Bid: 172.00
Ask: 180.00
Change: 11.00 (6.67%)
Spread: 8.00 (4.651%)
Open: 165.00
High: 179.50
Low: 165.00
Prev. Close: 165.00
ITX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

27 Jan 2014 07:00

RNS Number : 5233Y
Revolymer PLC
27 January 2014
 



27th January, 2014

Revolymer plc

Directorate Change

 

Revolymer plc ("Revolymer" or the "Company"), the British polymer technology company, announces today that its CEO, Dr Roger Pettman, will leave the Company with effect from 31 January, 2014.

Dr. Pettman has been CEO of the business since its inception in 2005 and led the flotation on the AIM Market in July 2012. He has played a significant role driving the development of a broad portfolio of polymer-based IP which is now being applied to improve the performance of a variety of consumer products within the fast moving consumer goods industry and other industrial markets.

The Company has recently used its technology to enter the nicotine gum market in Canada, and is exploring expansion of this business area to the EU and USA.

Dr Pettman's particular expertise within Revolymer has been in the establishment of the business, having identified the business model of using novel polymers to improve the performance of existing consumer products. He is now looking forward to working on establishing other new ventures. The Board thanks Dr. Pettman for his dedicated service to the Company over many years, and wishes him well in his new endeavours. The shares owned by Dr Pettman are subject to an orderly marketing agreement, which expires on 31 December 2014.

The Board is taking steps to identify a new CEO with the commercial and operational experience to execute the Company's strategy of delivering commercialisation deals for its IP portfolio. Dr Bryan Dobson, Chairman of the Revolymer Remuneration Committee, is leading the search for the Company.

In the meantime, Revolymer CFO and Company Secretary Rob Cridland will become acting CEO, working closely with Dr David Pears, Chief Technology Officer, and Dr Jonathan Swanston, who heads the commercialisation of the Company's nicotine gum globally.

Ends

For further information please contact:

Revolymer plc

+44 (0) 1244 283 500

Rob Cridland

Panmure Gordon (UK) Limited

+44 (0) 20 7886 2500

Callum Stewart / Adam James (Corporate Finance)

Adam Pollock / Charles Leigh-Pemberton (Corporate Broking)

Citigate Dewe Rogerson

+44 (0)20 7638 9571

David Dible / Ginny Pulbrook / Malcolm Robertson

 

About Revolymer

Revolymer is a technology company that designs, develops and formulates novel polymers to improve the performance of existing consumer products within the FMCG and other industrial markets. Revolymer's strategy is to generate significant and growing revenue streams by licensing its unique and proprietary technologies to manufacturers and marketers within these global high value markets. Current applications for the Group's technologies are in the household products, personal care and coatings & adhesives markets (together "Consumer Specialties") and the medicated chewing gum and confectionery chewing gum (together "Gum") markets.

www.revolymer.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUNUORSSAAUAR
Date   Source Headline
27th Jul 20219:00 amRNSPrice Monitoring Extension
27th Jul 20217:00 amRNSTrading Statement
19th Jul 202111:05 amRNSSecond Price Monitoring Extn
19th Jul 202111:00 amRNSPrice Monitoring Extension
19th Jul 20217:00 amRNSRemoval of US Securities Law Restrictions
24th Jun 20213:18 pmRNSResult of Annual General Meeting
18th Jun 20217:00 amRNSChanges to AGM Arrangements, Investor Presentation
9th Jun 20219:00 amRNSPrice Monitoring Extension
9th Jun 20217:00 amRNSCompleted New Funding with Institutional Investors
8th Jun 20212:05 pmRNSSecond Price Monitoring Extn
8th Jun 20212:00 pmRNSPrice Monitoring Extension
8th Jun 202111:05 amRNSSecond Price Monitoring Extn
8th Jun 202111:00 amRNSPrice Monitoring Extension
8th Jun 20217:00 amRNSTrading Update
27th May 20217:00 amRNSNotice of AGM
20th May 20214:41 pmRNSSecond Price Monitoring Extn
20th May 20214:35 pmRNSPrice Monitoring Extension
20th May 20217:00 amRNSItaconix receives the LSE's Green Economy Mark
9th Apr 20211:07 pmRNSIssue of Shares, Director/PDMR Dealings
30th Mar 20217:00 amRNSFull Year Results Ended 31 December 2020
24th Mar 202111:06 amRNSSecond Price Monitoring Extn
24th Mar 202111:00 amRNSPrice Monitoring Extension
24th Mar 20217:00 amRNSNotice of Final Results and Investor Presentation
23rd Mar 20212:06 pmRNSSecond Price Monitoring Extn
23rd Mar 20212:00 pmRNSPrice Monitoring Extension
23rd Mar 202111:05 amRNSSecond Price Monitoring Extn
23rd Mar 202111:00 amRNSPrice Monitoring Extension
28th Jan 20212:06 pmRNSSecond Price Monitoring Extn
28th Jan 20212:01 pmRNSPrice Monitoring Extension
27th Jan 202111:06 amRNSSecond Price Monitoring Extn
27th Jan 202111:00 amRNSPrice Monitoring Extension
26th Jan 202111:05 amRNSSecond Price Monitoring Extn
26th Jan 202111:00 amRNSPrice Monitoring Extension
26th Jan 20217:00 amRNSTrading Update for the year ended 31 December 2020
21st Jan 202111:05 amRNSSecond Price Monitoring Extn
21st Jan 202111:01 amRNSPrice Monitoring Extension
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn
18th Jan 20212:01 pmRNSPrice Monitoring Extension
14th Jan 20214:41 pmRNSSecond Price Monitoring Extn
14th Jan 20214:35 pmRNSPrice Monitoring Extension
14th Jan 20212:06 pmRNSSecond Price Monitoring Extn
14th Jan 20212:01 pmRNSPrice Monitoring Extension
14th Jan 20217:00 amRNSAppointment of new Vice President, Operations
8th Jan 202111:06 amRNSSecond Price Monitoring Extn
8th Jan 202111:00 amRNSPrice Monitoring Extension
30th Dec 202011:05 amRNSSecond Price Monitoring Extn
30th Dec 202011:00 amRNSPrice Monitoring Extension
29th Dec 20204:41 pmRNSSecond Price Monitoring Extn
29th Dec 20204:36 pmRNSPrice Monitoring Extension
3rd Nov 20207:00 amRNSAppointment of New Marketing and Sales Executive

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.